History and biological significance of GPCR heteromerization in the neuroendocrine system

Neuroendocrinology

Volumn 95, Issue 3, 2012, Pages 223-231

  Tadagaki, Kenjiro ^a   Jockers, Ralf ^a   Kamal, Maud ^a  

^a INSERM   (France)

Author keywords

Dynamics; Functional cross talk; G protein coupled receptor; Heteromerization; Physical interaction

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; LUTEINIZING HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; RETINA S ANTIGEN;

BINDING SITE; CELL STRAIN HEK293; CONFORMATIONAL TRANSITION; HUMAN; NEUROENDOCRINE SYSTEM; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NEUROSECRETORY SYSTEMS; PROTEIN MULTIMERIZATION; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84860741916     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000330000     Document Type: Review

References (65)

1. Lohse MJ: Dimerization in GPCR mobility and signaling. Curr Opin Pharmacol 2010; 10: 53-58.
2. Zoli M, Agnati LF, Hedlund PB, Li XM, Ferre S, Fuxe K: Receptor-receptor interactions as an integrative mechanism in nerve cells. Mol Neurobiol 1993; 7: 293-334.
3. Waldhoer M, Fong J, Jones RM, Lunzer MM, Sharma SK, Kostenis E, Portoghese PS, Whistler JL: A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci USA 2005; 102: 9050-9055. (Pubitemid 40881076)
4. Yekkirala AS, Lunzer MM, McCurdy CR, Powers MD, Kalyuzhny AE, Roerig SC, Portoghese PS: N-naphthoyl-{beta}-naltrexamine (NNTA), a highly selective and potent activator of {micro}/{kappa}-opioid heteromers. Proc Natl Acad Sci USA 2011; 108: 5098-5103.
5. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, George SR: D1-d2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 2007; 104: 654-659. (Pubitemid 46123080)
6. Ferre S, Franco R: Oligomerization of G-protein-coupled receptors: A reality. Curr Opin Pharmacol 2010; 10: 1-5.
7. Limbird LE, Meyts PD, Lefkowitz RJ: Betaadrenergic receptors: Evidence for negative cooperativity. Biochem Biophys Res Commun 1975; 64: 1160-1168.
8. Fuxe K, Agnati LF, Benfenati F, Celani M, Zini I, Zoli M, Mutt V: Evidence for the existence of receptor-receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. J Neural Transm Suppl 1983; 18: 165-179.
9. Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, Bouvier M: A peptide derived from a beta2-Adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 1996; 271: 16384-16392. (Pubitemid 26236264)
10. Bouvier M: Oligomerization of G-proteincoupled transmitter receptors. Nat Rev Neurosci 2001; 2: 274-286.
11. Angers S, Salahpour A, Bouvier M: Dimerization: An emerging concept for G proteincoupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 2002; 42: 409-435. (Pubitemid 34160532)
12. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M: Detection of beta 2-Adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 2000; 97: 3684-3689. (Pubitemid 30183363)
13. Overton MC, Blumer KJ: G-protein-coupled receptors function as oligomers in vivo. Curr Biol 2000; 10: 341-344. (Pubitemid 30186140)
14. McVey M, Ramsay D, Kellett E, Rees S, Wilson S, Pope AJ, Milligan G: Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J Biol Chem 2001; 276: 14092-14099.
15. Maurel D, Comps-Agrar L, Brock C, Rives ML, Bourrier E, Ayoub MA, Bazin H, Tinel N, Durroux T, Prezeau L, Trinquet E, Pin JP: Cell-surface protein-protein interaction analysis with time-resolved FRET and snaptag technologies: Application to GPCR oligomerization. Nat Methods 2008; 5: 561-567. (Pubitemid 351761765)
16. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, Palczewski K: Atomic-force microscopy: Rhodopsin dimers in native disc membranes. Nature 2003; 421: 127-128. (Pubitemid 36090969)
17. Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, Engel A: Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 2003; 278: 21655-21662. (Pubitemid 36792566)
18. Jones KA, Borowsky B, Tamm JA, Gerald C: GABA(B) receptors function as a heterotrimeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 1998; 396: 674-679. (Pubitemid 29003945)
19. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, Marshall FH: Heterodimerization is required for the formation of a functional GABA(b) receptor. Nature 1998; 396: 679-682. (Pubitemid 29003946)
20. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, Zuker CS: Mammalian sweet taste receptors. Cell 2001; 106: 381-390. (Pubitemid 32772621)
21. Nelson G, Chandrashekar J, Hoon MA, Feng L, Zhao G, Ryba NJ, Zuker CS: An amino-Acid taste receptor. Nature 2002; 416: 199-202. (Pubitemid 34246480)
22. Jordan BA, Devi LA: G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999; 399: 697-700. (Pubitemid 29289066)
23. Prinster SC, Hague C, Hall RA: Heterodimerization of G protein-coupled receptors: Specificity and functional significance. Pharmacol Rev 2005; 57: 289-298. (Pubitemid 41196951)
24. Milligan G: G protein-coupled receptor hetero-dimerization: Contribution to pharmacology and function. Br J Pharmacol 2009; 158: 5-14.
25. Whorton MR, Bokoch MP, Rasmussen SG, Huang B, Zare RN, Kobilka B, Sunahara RK: A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci USA 2007; 104: 7682-7687. (Pubitemid 47185966)
26. Bayburt TH, Vishnivetskiy SA, McLean MA, Morizumi T, Huang CC, Tesmer JJ, Ernst OP, Sligar SG, Gurevich VV: Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding. J Biol Chem 2011; 286: 1420-1428.
27. Bayburt TH, Leitz AJ, Xie G, Oprian DD, Sligar SG: Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J Biol Chem 2007; 282: 14875-14881. (Pubitemid 47093370)
28. Ernst OP, Gramse V, Kolbe M, Hofmann KP, Heck M: Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit. Proc Natl Acad Sci USA 2007; 104: 10859-10864. (Pubitemid 47175191)
29. Levoye A, Dam J, Ayoub MA, Guillaume JL, Jockers R: Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers. EMBO Rep 2006; 7: 1094-1098. (Pubitemid 44660563)
30. Bulenger S, Marullo S, Bouvier M: Emerging role of homo- and heterodimerization in Gprotein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 2005; 26: 131-137. (Pubitemid 40313592)
31. Romano C, Yang WL, O'Malley KL: Metabotropic glutamate receptor 5 is a disulfidelinked dimer. J Biol Chem 1996; 271: 28612-28616. (Pubitemid 26374686)
32. Schwartz TW, Frimurer TM, Holst B, Rosenkilde MM, Elling CE: Molecular mechanism of 7TM receptor activation - A global toggle switch model. Annu Rev Pharmacol Toxicol 2006; 46: 481-519. (Pubitemid 43271198)
33. Schwartz TW, Holst B: Ago-Allosteric modulation and other types of allostery in dimeric 7TM receptors. J Recept Signal Transduct Res 2006; 26: 107-128.
34. May LT, Leach K, Sexton PM, Christopoulos A: Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 2007; 47: 1-51. (Pubitemid 46277033)
35. Durroux T: Principles: A model for the allosteric interactions between ligand binding sites within a dimeric GPCR. Trends Pharmacol Sci 2005; 26: 376-384. (Pubitemid 40848499)
36. Springael JY, Le Minh PN, Urizar E, Costagliola S, Vassart G, Parmentier M: Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers. Mol Pharmacol 2006; 69: 1652-1661.
37. El-Asmar L, Springael JY, Ballet S, Andrieu EU, Vassart G, Parmentier M: Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 2005; 67: 460-469. (Pubitemid 40216739)
38. Pellissier LP, Barthet G, Gaven F, Cassier E, Trinquet E, Pin JP, Marin P, Dumuis A, Bockaert J, Baneres JL, Claeysen S: G protein activation by serotonin type 4 receptor dimers: Evidence that turning on two protomers is more efficient. J Biol Chem 2011; 286: 9985-9997.
39. Kamal M, Maurice P, Jockers R: Expanding the concept of G protein-coupled receptor (GPCR) dimer asymmetry towards GPCRinteracting proteins. Pharmaceuticals 2011; 4: 273-284.
40. Baneres JL, Parello J: Structure-based analysis of GPCR function: Evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 2003; 329: 815-829. (Pubitemid 36629373)
41. Maurice P, Daulat AM, Turecek R, Ivankova-Susankova K, Zamponi F, Kamal M, Clement N, Guillaume JL, Bettler B, Gales C, Delagrange P, Jockers R: Molecular organization and dynamics of the melatonin MT 1 receptor/RGS20/G(i) protein complex reveal asymmetry of receptor dimers for RGS and G(i) coupling. EMBO J 2010; 29: 3646-3659.
42. Fung JJ, Deupi X, Pardo L, Yao XJ, Velez-Ruiz GA, Devree BT, Sunahara RK, Kobilka BK: Ligand-regulated oligomerization of beta(2)-Adrenoceptors in a model lipid bilayer. Embo J 2009; 28: 3315-3328.
43. Kamal M, Jockers R: Biological significance of GPCR heteromerization in the neuro-endocrine system. Front Endocrin 2011; 2: 2. doi: 10.3389/ fendo.2011.00002
44. Kaykas A, Yang-Snyder J, Heroux M, Shah KV, Bouvier M, Moon RT: Mutant frizzled 4 associated with vitreoretinopathy traps wild-type frizzled in the endoplasmic reticulum by oligomerization. Nat Cell Biol 2004; 6: 52-58. (Pubitemid 38425730)
45. González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, Lopez-Gimenez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC: Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008; 452: 93-97. (Pubitemid 351355090)
46. Kamal M, Jockers R: Bitopic ligands: All-inone orthosteric and allosteric. F1000 Biol Rep 2009; 1.
47. Pin JP, Neubig R, Bouvier M, Devi L, Filizola M, Javitch JA, Lohse MJ, Milligan G, Palczewski K, Parmentier M, Spedding M: International union of basic and clinical pharmacology. LXVII. Recommendations for the recognition and nomenclature of G proteincoupled receptor heteromultimers. Pharmacol Rev 2007; 59: 5-13. (Pubitemid 46335687)
48. Magalhaes AC, Holmes KD, Dale LB, Comps-Agrar L, Lee D, Yadav PN, Drysdale L, Poulter MO, Roth BL, Pin JP, Anisman H, Ferguson SS: CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nat Neurosci 2010; 13: 622-629.
49. Ferre S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, Lohse MJ, Mackie K, Milligan G, Pfleger KD, Pin JP, Volkow ND, Waldhoer M, Woods AS, Franco R: Building a new conceptual framework for receptor heteromers. Nat Chem Biol 2009; 5: 131-134.
50. Pei L, Li S, Wang M, Diwan M, Anisman H, Fletcher PJ, Nobrega JN, Liu F: Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Nat Med 2010; 16: 1393-1395.
51. He SQ, Zhang ZN, Guan JS, Liu HR, Zhao B, Wang HB, Li Q, Yang H, Luo J, Li ZY, Wang Q, Lu YJ, Bao L, Zhang X: Facilitation of muopioid receptor activity by preventing deltaopioid receptor-mediated codegradation. Neuron 2011; 69: 120-131.
52. Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, Lim M, Maillet E, Junek M, Cahill CM, Harkany T, Devi LA: Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal 2010; 3:ra54.
53. Urizar E, Montanelli L, Loy T, Bonomi M, Swillens S, Gales C, Bouvier M, Smits G, Vassart G, Costagliola S: Glycoprotein hormone receptors: Link between receptor homodimerization and negative cooperativity. Embo J 2005; 24: 1954-1964. (Pubitemid 40896167)
54. Rivero-Muller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, Rahman N, Ji TH, Huhtaniemi I: Rescue of defective G proteincoupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci USA 2010; 107: 2319-2324.
55. Albizu L, Cottet M, Kralikova M, Stoev S, Seyer R, Brabet I, Roux T, Bazin H, Bourrier E, Lamarque L, Breton C, Rives ML, Newman A, Javitch J, Trinquet E, Manning M, Pin JP, Mouillac B, Durroux T: Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat Chem Biol 2010; 6: 587-594.
56. Sakai T, Aoyama M, Kusakabe T, Tsuda M, Satake H: Functional diversity of signaling pathways through G protein-coupled receptor heterodimerization with a species-specific orphan receptor subtype. Mol Biol Evol 2009; 27: 1097-1106.
57. Levoye A, Dam J, Ayoub MA, Guillaume JL, Couturier C, Delagrange P, Jockers R: The orphan GPR50 receptor specifically inhibits MT(1) melatonin receptor function through heterodimerization. EMBO J 2006; 25: 3012-3023. (Pubitemid 44106754)
58. Vischer HF, Nijmeijer S, Smit MJ, Leurs R: Viral hijacking of human receptors through heterodimerization. Biochem Biophys Res Commun 2008; 377: 93-97.
59. Nijmeijer S, Leurs R, Smit MJ, Vischer HF: The Epstein-Barr virus-encoded G proteincoupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges G - I proteins, and constitutively impairs CXCR4 functioning. J Biol Chem 2010; 285: 29632-29641.
60. Hirono M, Yoshioka T, Konishi S: GABA(b) receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses. Nat Neurosci 2001; 4: 1207-1216. (Pubitemid 33135626)
61. Rives ML, Vol C, Fukazawa Y, Tinel N, Trinquet E, Ayoub MA, Shigemoto R, Pin JP, Prezeau L: Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration. Embo J 2009; 28: 2195-2208.
62. Prezeau L, Rives ML, Comps-Agrar L, Maurel D, Kniazeff J, Pin JP: Functional crosstalk between GPCRs: With or without oligomerization. Curr Opin Pharmacol 2010; 10: 6-13.
63. Rozenfeld R, Devi LA: Receptor heteromerization and drug discovery. Trends Pharmacol Sci 2010; 31: 124-130.
64. Mustafa S, Ayoub MA, Pfleger KD: Uncovering GPCR hetero-biased ligands. Drug Discov Today: Technol 2010; 7:e77-e85.
65. Daulat AM, Maurice P, Jockers R: Recent methodological advances in the discovery of GPCR-Associated protein complexes. Trends Pharmacol Sci 2009; 30: 72-78.